tiprankstipranks
Trending News
More News >
THC Farmaceuticals Inc (CBDG)
OTHER OTC:CBDG
US Market
Advertisement

THC Farmaceuticals (CBDG) Income Statement

Compare
22 Followers

THC Farmaceuticals Income Statement

Last quarter (Q3 2022), THC Farmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, THC Farmaceuticals's net income was $-3.16K. See THC Farmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 10.00K$ 2.23K$ 7.58K$ 10.19K
Gross Profit
$ -4.95K$ 6.19K$ 1.28K$ 7.58K$ 7.56K
Operating Expenses
$ -25.00K$ 14.68K$ 19.09K$ 39.32K$ 165.65K
Depreciation and Amortization
$ 4.95K$ 3.81K$ 952.00$ 952.00$ 953.00
EBITDA
$ -25.00K$ 429.87K$ -15.85K$ -119.70K$ -994.19K
Operating Income
$ -29.95K$ -8.49K$ -17.81K$ -32.70K$ -158.09K
Other Income/Expenses
$ 0.00$ 434.55K$ 1.00K$ -87.95K$ -837.05K
Pretax Income
$ -29.95K$ 426.06K$ -16.81K$ -120.65K$ -995.14K
Net Income
$ -14.98K$ 426.90K$ -8.42K$ -60.45K$ -498.57K
Per Share Metrics
Basic EPS
$ 0.00$ 0.02$ 0.00$ 0.00$ -0.03
Diluted EPS
$ 0.00$ 0.02$ 0.00$ 0.00$ -0.03
Weighted Average Shares Outstanding
18.13M 18.13M 18.13M 16.63M 16.63M
Weighted Average Shares Outstanding (Diluted)
18.13M 18.13M 18.13M 16.63M 16.63M
Currency in USD

THC Farmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis